[["thyroid cancer", "is a", "comparatively rare malignancy"], ["thyroid cancer", "represents", "the vast majority of endocrine cancers"], ["thyroid cancer incidence", "is increasing", ""], ["most differentiated thyroid cancers", "have", "an excellent prognosis if diagnosed early and treated appropriately"], ["aggressive histologic subtypes and variants", "carry", "a worse prognosis"], ["positron emission tomography (PET) and PET/CT", "has been used increasingly in", "patients with thyroid cancers"], ["FDG-PET/CT", "exists in the work-up of", "patients with differentiated thyroid cancer status post thyroidectomy"], ["FDG-PET/CT", "is useful in", "the initial staging of high-risk patients with less differentiated subtypes"], ["less differentiated subtypes", "are", "clinically more aggressive"], ["FDG-PET/CT", "may help in defining", "the extent of disease in some patients with medullary thyroid carcinoma"], ["FDOPA", "has emerged as", "an alternate and more promising radiotracer"], ["FDG-PET/CT", "may help in", "radiotherapy planning"], ["FDG-PET/CT", "may help in assessing", "the response to radiotherapy, embolization, or experimental systemic treatments"], ["(124)Iodine PET/CT", "may serve a role in", "obtaining lesional dosimetry for better planning of treatment with (131)iodine"], ["thyroid cancer", "is not a", "monolithic disease"], ["different stages and histologic entities", "require", "different approaches in imaging and individualized therapy"]]